Podrobno

Association between the ANGPT2 rs2442598 polymorphism and diabetic nephropathy in Slovenian patients with type 2 diabetes mellitus
ID Nussdorfer, Petra (Avtor), ID Letonja, Jernej (Avtor), ID Završnik, Matej (Avtor), ID Matos, Boštjan (Avtor), ID Petrovič, Danijel (Avtor), ID Cilenšek, Ines (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (17,40 MB)
MD5: CEB83B3AB70B27948675E3B56B7B8383
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2073-4425/17/4/373 Povezava se odpre v novem oknu

Izvleček
Background: The aim of our study was to evaluate the association of angiopoietin 2 (ANGPT2) rs2442598 and vascular endothelial growth factor A (VEGFA) rs2010963 with diabetic nephropathy (DN) in Slovenian subjects with type 2 diabetes mellitus (T2DM). Angiopoietin–endothelial tyrosine kinase receptor (Ang-Tie2) and VEGF-A signaling regulate glomerular endothelial stability and permeability and may contribute to DN susceptibility. Methods: We conducted a case–control study including 897 unrelated Slovenian subjects with T2DM (344 DN cases; 553 long-standing T2DM controls without DN). ANGPT2 rs2442598 and VEGFA rs2010963 were genotyped using TaqMan assays. Genetic associations were analysed using co-dominant, additive, dominant, and recessive genetic models with logistic regression adjusted for waist circumference, systolic blood pressure, fasting glucose, and triglycerides. Results: ANGPT2 rs2442598 was significantly associated with DN, with increased risk in carriers of the C allele, including a significant additive per allele effect (OR 1.39, 95% CI 1.10–1.74) and a dominant model effect (OR 1.47, 95% CI 1.11–1.96). In contrast, VEGFA rs2010963 showed no evidence of association across genetic models. Conclusions: In Slovenian patients with T2DM, ANGPT2 rs2442598 is associated with DN, whereas VEGFA rs2010963 is not. This association suggests that ANGPT2 genetic variation may influence DN risk and supports further functional work to define the biological effects of rs2442598.

Jezik:Angleški jezik
Ključne besede:diabetic nephropathy, type 2 diabetes mellitus, ANGPT2, VEGFA, polymorphism
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:13. str.
Številčenje:Vol. 17, iss. 4, art. 373
PID:20.500.12556/RUL-184379 Povezava se odpre v novem oknu
UDK:616.379
ISSN pri članku:2073-4425
DOI:10.3390/genes17040373 Povezava se odpre v novem oknu
COBISS.SI-ID:275345667 Povezava se odpre v novem oknu
Datum objave v RUL:06.07.2026
Število ogledov:33
Število prenosov:37
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Genes
Skrajšan naslov:Genes
Založnik:MDPI
ISSN:2073-4425
COBISS.SI-ID:523100185 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:diabetična nefropatija, sladkorna bolezen, tip 2, polimorfizem

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0326
Naslov:Ginekologija in reprodukcija: Genomika za personalizirano medicino

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj